SCHEMBL7348111

SCHEMBL7348111

CCCNC(C(=O)O)C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.40
HDAC2 Q92769 2/20 0.40
CHRM1 P11229 1/20 0.40
AKR1A1 P14550 1/20 0.40
CHRM3 P20309 1/20 0.40
HTR2A P28223 1/20 0.40
HTR2C P28335 1/20 0.40
ADRA1A P35348 1/20 0.40
HRH1 P35367 1/20 0.40
DRD3 P35462 1/20 0.40
SLC6A3 Q01959 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
MMP1 P03956 1/20 0.39
MMP2 P08253 1/20 0.39
MMP3 P08254 1/20 0.39
MMP9 P14780 1/20 0.39
ALOX15 P16050 1/20 0.34
CA2 P00918 1/20 0.34
MAPK1 P28482 1/20 0.34
KDM4C Q9H3R0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6557889 0.83 EPHX1 (0.46) GPR84SMN1; SMN2EPHX1FFAR1MAPT
SCHEMBL1007236 0.83 LDHA (0.33) TDP1SMN1; SMN2LMNA
SCHEMBL7597231 0.81 EPHX1 (0.50) GPR84SMN1; SMN2EPHX1FFAR1MAPT
SCHEMBL11177014 0.81 EPHX1 (0.50) GPR84SMN1; SMN2EPHX1FFAR1MAPT
SCHEMBL18064432 0.81 CES2 (0.38) ALOX15MAPK1
SCHEMBL16395664 0.80 CHRM1 (0.39) HDAC1HDAC2CHRM1AKR1A1CHRM3
SCHEMBL28310178 0.79 HDAC1 (0.40) HDAC1HDAC2CHRM1AKR1A1CHRM3
SCHEMBL11186166 0.78 CHRM1 (0.38) HDAC1HDAC2CHRM1AKR1A1CHRM3
SCHEMBL6342528 0.78 LDHA (0.30)
SCHEMBL2644360 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5436240-A Schizophrenia, Parkinson's disease, depression or hypotensive agents using tricyclic amines THE UPJOHN COMPANY (US) 1995-07-25 US disclosed
EP-0480939-B1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY UPJOHN CO (US) 1995-01-25 EP disclosed
US-5273975-A Heterocyclic amines having central nervous system activity THE UPJOHN COMPANY (US) 1993-12-28 US disclosed
EP-0480939-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY. UPJOHN CO (US) 1992-04-22 EP disclosed
WO-1990015058-A1 HETEROCYCLIC AMINES HAVING CENTRAL NERVOUS SYSTEM ACTIVITY THE UPJOHN COMPANY (US) 1990-12-13 WO disclosed